Opioids for chronic non-cancer pain: A critical view from the other side of the pond

Minerva Anestesiologica

Volumn 82, Issue 1, 2016, Pages 97-102

  Fanelli, Guido ^a,b   Tölle, Thomas R ^c   De Andrés, José ^b,d,e   Häuser, Winfried ^c   Allegri, Massimo ^a,b   Montella, Silvana ^a,b   Kress, Hans G ^f  

^a UNIVERSITY OF PARMA   (Italy)

^b SIMPAR (Study in Multidisciplinary Pain Research Group)   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Analgesics, Opioid; Chronic Pain; Opioid Related Disorders

Indexed keywords

FENTANYL; HYDROCODONE; MORPHINE; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; TAPENTADOL;

ANALGESIA; CARDIOVASCULAR RISK; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CLINICAL PRACTICE; DRUG MISUSE; FOLLOW UP; HUMAN; HUMAN RIGHTS; MEDICAL DOCUMENTATION; MENTAL HEALTH; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NARCOTIC DEPENDENCE; PAIN INTENSITY; PATIENT ASSESSMENT; PRESCRIPTION; REVIEW; SYSTEMATIC REVIEW (TOPIC); WESTERN EUROPE; OPIOID-RELATED DISORDERS; UNITED STATES;

ANALGESICS, OPIOID; CHRONIC PAIN; HUMANS; OPIOID-RELATED DISORDERS; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 84957960397     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health 2011;11:770.
2. Gaskell H, Moore A. Pain treatment-bad news and good. J Am Geriatr Soc 2014;62:1413-4.
3. Riera CE, Huising MO, Follett P, Leblanc M, Halloran J, Van Andel R, et al. TRPV1 pain receptors regulate longevity and metabolism by neuropeptide signaling. Cell 2014;157:1023-36.
4. Lohman D, Schleifer R, Amon JJ. Access to pain treatment as a human right. BMC Med 2010;20;8:8
5. Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011;152:2673-4.
6. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
7. Cheung CW, Qiu Q, Choi SW, Moore B, Goucke R, Irwin M.Chronic opioid therapy for chronic non-cancer pain: A review and comparison of treatment guidelines. Pain Physician 2014;17:401-14.
8. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: A systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38-47.
9. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I,et al. The effectiveness and risks of longor term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to prevention workshop. Ann Intern Med 2015;162:276-86.
10. Chaparro LE , Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared with placeo or other treatemtns for chronic low back pain: an update of the Cochrane review. Spine (Phila Pa 1976) 2014;39:556-63.
11. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and metaanalysis. Lancet Neurol 2015;14:162-73.
12. Franklin GM; American Academy of Neurology Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology. Neurology 2014;83:1277-84.
13. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008;11(2 Suppl):S63-88.
14. Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ 2015;350:g6380.
15. Campbell G, Nielsen S, Bruno R, Lintzeris N, Cohen M, Hall W, et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015;156:231-42.
16. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain 2015;156:569-76.
17. Fredheim OM, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC. Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trøndelag health study. Pain 2014;155:1213-21.
18. Marschall U, Lhoest H, Radbruch L, Häuser W. Longterm opioid therapy for chronic non-cancer pain in Germany. Eur J Pain. 2015 [Epub ahead of print].
19. Dart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EH. Assessment of the abuse of tapentadol immediate release: The first 24 months. J Opioid Manag 2012;8:395-402.
20. Butler SF, McNaughton EC, Black RA. Tapentadol abuse potential: A postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment. Pain Med 2015;16:119-30.
21. United Nations: International Narcotics Control Board. Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. International Narcotic Control Board; [Internet]. Available from: http://www.unodc.org/documents/lpo-brazil//noticias/2011/03-marco/Jife/Report-of-The-Board-on-The-availability-of-controlled-substances.pdf [cited on 2015, Dec 14].
22. Azevedo LF, Costa-Pereira A, Mendonça L, Dias CC, Castro-Lopes JM. Apopulation-based study on chronic pain and the use of opioids in Portugal. Pain 2013;154:2844-52.
23. Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, Vos T. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction 2014;109:1320-33.
24. Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 2012;23:37-44.
25. Binswanger IA, Glanz JM. Pharmaceutical opioids in the home and youth: implications for adult medical practice. Subst Abus 2015;36:141-3.
26. National Institute of Drug Abuse. The Science of Drug Abuse and Addiction; [Internet]. Available from: http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2014/americas-addiction-to-opioidsheroin-prescription-drug-abuse [cited on 2015, Dec 14].
27. Nickerson JW, Attaran A. The inadequate treatment of pain: collateral damage from the war on drugs. PLoS Med 2012;9:e1001153.
28. Fishbain DA, Lewis JE, Gao J. The pain suicidality association: A narrative review. Pain Med 2014;15:1835-49.
29. Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharmacol 2014;70:1159-72.
30. Weiner DK, Rudy TE, Morrow L, Slaboda J, Lieber S. The relationship between pain, neuropsychological performance, and physical function in community-dweling older adults with chronic low back pain. Pain Medicine 2006;7:60-70.
31. Moriarty O, McGuire BE. Finn DP. The effect of pain on cognitive function: A review of clinical and preclinical research. Progr Neurobiol 2001;93:385-404.
32. Kendall SE, Sjøgren P, Pimenta CA, Højsted J, Kurita GP. The cognitive effects of opioid in chronic non cancer pain. Pain 2010;150:225-30.
33. Kapur BM, Lala PK, Shaw JL. Pharmacogenetics of chronic pain management. Clin Biochem 2014;47:1169-87.
34. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006;166:2087-93.
35. Tölle TR, Sprenger T, Valet M. Opioid prescription in people with mental health problems-what is the way forward? Nat Clin Pract Neurol 2007;3:368-9.
36. Häuser W, Bock F, Engeser P, Tölle T, Willweber-Strumpfe A, Petzke F. Long-term opioid use in non-cancer pain. Dtsch Arztebl Int 2014;111:732-40.